The Nanowear Wearable Covid-19 Observational and Analysis Trend

Last updated: November 7, 2023
Sponsor: Nanowear Inc.
Overall Status: Active - Recruiting

Phase

N/A

Condition

Covid-19

Treatment

Observational Study - no intervention

Clinical Study ID

NCT04717024
NWCT20-SS-002
  • Ages > 18
  • All Genders

Study Summary

The NanoCOAT study is a multi-center, prospective, non-randomized, feasibility, observational, non-significant risk study. The NanoCOAT study will enroll a minimum of 10 and a maximum of 100 subjects in a potential for a multi-site in order to collect data and analyze physiological and biometric trends due to Covid-19.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Subject has provided informed consent
  • Male or female over the age of 18 years
  • The patient is currently hospitalized with a primary diagnosis of Covid-19

Exclusion

Exclusion Criteria:

  • Subject is unwilling or unable to wear the vest during hospitalization.
  • Subjects who are pregnant.
  • Subject is intubated or admitted to ICU
  • Subject has an implantable cardiac device (i.e pacemaker or internal cardioverterdefibrillator)

Study Design

Total Participants: 100
Treatment Group(s): 1
Primary Treatment: Observational Study - no intervention
Phase:
Study Start date:
September 15, 2020
Estimated Completion Date:
December 31, 2023

Connect with a study center

  • Hackensack University Medical Center

    Hackensack, New Jersey 07601
    United States

    Site Not Available

  • Maimonides Medical Center

    Brooklyn, New York 11219
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.